Results 31 to 40 of about 171,216,168 (330)

Rapid corticosteroid taper versus standard of care for immune checkpoint inhibitor induced nephritis: a single-center retrospective cohort study

open access: yesJournal for ImmunoTherapy of Cancer, 2021
Background Current guidelines for treatment of immune checkpoint inhibitor (ICI)-induced nephritis are not evidence based and may lead to excess corticosteroid exposure. We aimed to compare a rapid corticosteroid taper to standard of care.
Meghan D Lee   +8 more
semanticscholar   +1 more source

Efficacy and safety of sofosbuvir/velpatasvir versus the standard of care in adults hospitalized with COVID-19: a single-centre, randomized controlled trial

open access: yesJournal of Antimicrobial Chemotherapy, 2021
Objectives Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the COVID-19 pandemic. The majority of patients experience asymptomatic to mild self-limited disease, but some cases progress to respiratory and multi-organ ...
B. Sayad   +14 more
semanticscholar   +1 more source

Ethical Issues Regarding Nonsubjective Psychedelics as Standard of Care

open access: yesCambridge Quarterly of Healthcare Ethics, 2022
Evidence suggests that psychedelics bring about their therapeutic outcomes in part through the subjective or qualitative effects they engender and how the individual interprets the resulting experiences.
D. Yaden, B. Earp, R. Griffiths
semanticscholar   +1 more source

The Edoxaban Hokusai VTE PEDIATRICS Study: An open‐label, multicenter, randomized study of edoxaban for pediatric venous thromboembolic disease

open access: yesResearch and Practice in Thrombosis and Haemostasis, 2020
Background Little evidence is available for treatment of pediatric venous thromboembolism (VTE). Large randomized controlled trials are challenging in children.
Cornelia Heleen vanOmmen   +9 more
doaj   +1 more source

Developing Standardized Peer Review Guidelines For Adverse Events

open access: yesJournal of Scientific Innovation in Medicine, 2021
Introduction: Adverse events (AE) are common in medical practice and are associated with poor patient outcomes, including prolonged hospitalizations, increased readmission rates, and reduced quality of life, which lead to increased hospital expenditures.
Morgan Goodman   +3 more
doaj   +1 more source

Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk

open access: yesFrontiers in Endocrinology, 2021
Many factors must be considered and discussed with women when initiating a contraceptive method and the risk of venous thromboembolism (VTE) is one of them.
Laure Morimont   +7 more
doaj   +1 more source

Standardizing the Care of Bronchiolitis [PDF]

open access: yesArchives of Pediatrics & Adolescent Medicine, 1998
To study the effect of an educational intervention on the management of hospitalized infants with bronchiolitis.Sequential, prospective cohort study.A 235-bed children's hospital with nearly all private rooms.Consecutively admitted, previously healthy children younger than 24 months with symptoms of bronchiolitis.
P M, Adcock, C L, Sanders, G S, Marshall
openaire   +2 more sources

The Crisis in Standards of Care [PDF]

open access: yesHastings Center Report, 2021
AbstractSince the start of the Covid‐19 pandemic, debates have waged about “crisis standards of care” (“CSC”)—the guidelines for the allocation of resources if those resources are too scarce to meet the needs of all patients. The Hastings Center Report's September‐October 2021 issue features a collection of pieces on this debate.
openaire   +2 more sources

Management of Differentiated Thyroid Cancer: The Standard of Care

open access: yesJournal of Nuclear Medicine, 2021
In the past decade, the management of differentiated thyroid cancer (DTC) underwent a paradigm shift toward the use of risk stratification with the goal of maximizing the benefit and minimizing the morbidity of radioiodine (131I) therapy. 131I therapy is
A. Avram   +3 more
semanticscholar   +1 more source

Five Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-cell Lymphoma: Results from the US Lymphoma CAR T Consortium

open access: yesJournal of Clinical Oncology
PURPOSE Axicabtagene ciloleucel (axi-cel) is an autologous CD19 chimeric antigen receptor (CAR) T-cell therapy that is approved for the treatment of relapsed or refractory large B-cell lymphoma.
M. Jain   +31 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy